The Role of Embolic Agents in Endovascular Treatment of Intracranial Arteriovenous Malformations and Tumors

2005 ◽  
pp. 187-207 ◽  
Author(s):  
Ricardo A. Hanel ◽  
Bernard R. Bendok ◽  
Jay U. Howington ◽  
Elad I. Levy ◽  
Lee R. Guterman ◽  
...  
Keyword(s):  
Endovascular Treatment ◽  
Arteriovenous Malformations ◽  
Intracranial Arteriovenous Malformations ◽  
Embolic Agents

scholarly journals The Role Of Decompressive Hemnicraniectomies As Damage Control For Ruptured Intracranial Arteriovenous Malformations

2021 ◽  
pp. 101270
Author(s):  
Raphael Bertani ◽  
Stefan W. Koester ◽  
Karl R. Abi-Aad ◽  
Anna R. Kimata ◽  
Kevin L. Ma ◽  
...  
Keyword(s):  
Arteriovenous Malformations ◽  
Damage Control ◽  
Intracranial Arteriovenous Malformations

Embolic Agents and Microcatheters for Endovascular Treatment of Cerebral Arteriovenous Malformations

2020 ◽  
Vol 141 ◽  
pp. 383-388
Author(s):  
Matthew J. Triano ◽  
Jacques Lara-Reyna ◽  
Alexander J. Schupper ◽  
Kurt A. Yaeger
Keyword(s):  
Endovascular Treatment ◽  
Arteriovenous Malformations ◽  
Cerebral Arteriovenous Malformations ◽  
Embolic Agents

The Role of Neuroendovascular Therapy for the Treatment of Brain Arteriovenous Malformations

Neurosurgery ◽  
2006 ◽  
Vol 59 (suppl_5) ◽  
pp. S3-163-S3-177 ◽  
Author(s):  
David Fiorella ◽  
Felipe C. Albuquerque ◽  
Henry H. Woo ◽  
Cameron G. McDougall ◽  
Peter A. Rasmussen
Keyword(s):  
Arteriovenous Malformations ◽  
Treatment Plan ◽  
Multimodality Treatment ◽  
Clear Understanding ◽  
Technical Application ◽  
Embolic Agents ◽  
History Of ◽  
Application Potential ◽  
Cumulative Risks

Abstract NEUROENDOVASCULAR EMBOLIZATION REPRESENTS a critical component of the multidisciplinary management of cerebral arteriovenous malformations. Safe and effective embolization may be performed only in the context of a well-designed, rational treatment plan that is fundamentally based on a clear understanding of the natural history of the lesion, as well as the cumulative risks of multimodality treatment. This article outlines the role of neuroendovascular embolization in arteriovenous malformation therapy with a specific emphasis on decision making in the context of formulating a treatment plan. The authors also provide a summary of the available embolic agents and their technical application, potential intraprocedural and periprocedural complications, and postprocedural management.

scholarly journals Targeted endovascular treatment of haemorrhagic posterior fossa proliferative angiopathy

2018 ◽  
Vol 24 (4) ◽  
pp. 440-443 ◽  
Author(s):  
Suresh Giragani ◽  
Santhosh Kumar Pavunesan ◽  
Anandh Balasubramaniam
Keyword(s):  
Endovascular Treatment ◽  
Posterior Fossa ◽  
Clinical Features ◽  
Arteriovenous Malformations ◽  
Treatment Options ◽  
Focal Lesion ◽  
Imaging Findings ◽  
Endovascular Management ◽  
Vascular Abnormality

Cerebral proliferative angiopathy (CPA) is a rare vascular abnormality and separate from “classical” brain arteriovenous malformations. Haemorrhage due to proliferative angiopathy is rarely reported. We describe the clinical features, imaging findings and targeted endovascular management for a 12-year-old boy having proliferative angiopathy of the posterior fossa presenting with haemorrhage. Targeted endovascular embolisation in CPA is not previously described in the literature. The optimal treatment options for haemorrhagic CPA are debatable, and we wish to highlight the role of targeted treatment for culprit focal lesion demonstrable on imaging.

The role of ethylene–vinyl alcohol copolymer in association with other embolic agents for the percutaneous and endovascular treatment of type Ia endoleak

2018 ◽  
Vol 123 (8) ◽  
pp. 638-642 ◽  
Author(s):  
Anna Maria Ierardi ◽  
Marco Franchin ◽  
Federico Fontana ◽  
Gabriele Piffaretti ◽  
Matteo Crippa ◽  
...  
Keyword(s):  
Endovascular Treatment ◽  
Vinyl Alcohol ◽  
Ethylene Vinyl Alcohol ◽  
Ethylene Vinyl Alcohol Copolymer ◽  
Embolic Agents ◽  
Type Ia
Sign in / Sign up

Export Citation Format

Share Document